Doorstep medicine delivery for high-risk patients in India during COVID-19 lockdowns

September 21, 2021

Doorstep medicine delivery for high-risk patients in India during COVID-19 lockdowns

When COVID-19 lockdowns hit India, many people with chronic conditions, including high blood pressure and diabetes, were left unable to get their prescriptions. The India Hypertension Control Initiative made door-to-door deliveries to ensure that patients didn’t miss doses of life-saving medication.


Subscribe to the Resolve to Save Lives Newsletter

Subscribe to stay up to date on the latest news and learnings from our Cardiovascular Health and Prevent Epidemics teams, and our President and CEO Dr. Tom Frieden.